Valuation: Tianjin Chase Sun Pharmaceutical Co.,Ltd

Capitalization 11.03B 1.58B 1.35B 1.26B 1.17B 2.19B 143B 2.35B 14.5B 5.7B 68.17B 5.93B 5.81B 250B P/E ratio 2025 *
24.5x
P/E ratio 2026 * 20.4x
Enterprise value 11.03B 1.58B 1.35B 1.26B 1.17B 2.19B 143B 2.35B 14.5B 5.7B 68.17B 5.93B 5.81B 250B EV / Sales 2025 *
1.81x
EV / Sales 2026 * 1.67x
Free-Float
59.17%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.83%
1 week+3.69%
Current month+3.69%
1 month+1.11%
3 months-2.41%
6 months-8.29%
Current year+3.69%
More quotes
1 week 3.58
Extreme 3.58
3.65
1 month 3.51
Extreme 3.51
3.65
Current year 3.53
Extreme 3.53
3.65
1 year 3.08
Extreme 3.08
4.49
3 years 3.01
Extreme 3.01
6.8
5 years 3.01
Extreme 3.01
9.9
10 years 2.92
Extreme 2.92
9.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 2024-03-31
Director of Finance/CFO 57 2024-03-31
Corporate Officer/Principal 56 2019-04-25
Director TitleAgeSince
Director/Board Member 51 2019-04-23
Director/Board Member 45 2013-04-15
Director/Board Member 75 2017-12-27
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.83%+3.69%0.00%-36.52% 1.57B
+0.22%+0.77%-11.49%-28.38% 6.38B
-0.40%+1.75%-19.39%+22.82% 4.6B
-1.47%+2.74%+60.68%+55.20% 4.56B
+1.07%+4.92%+14.22%-39.41% 4.29B
-0.34%-0.84%-5.85%-6.29% 3.46B
-0.13%+1.46%+12.34%+35.43% 3.28B
+0.18%+6.20%+10.15%-21.39% 2.51B
+0.95%+3.76%+21.78%+5.27% 2B
+0.42%+3.19%+3.69%+55.64% 1.72B
Average +0.13%+0.60%+8.61%+4.24% 3.44B
Weighted average by Cap. +0.01%+0.59%+7.88%+2.80%
See all sector performances

Financials

2025 *2026 *
Net sales 6.09B 873M 748M 695M 648M 1.21B 78.7B 1.3B 8.01B 3.15B 37.65B 3.27B 3.21B 138B 6.62B 949M 812M 755M 704M 1.32B 85.5B 1.41B 8.7B 3.42B 40.9B 3.56B 3.48B 150B
Net income 449M 64.39M 55.14M 51.28M 47.8M 89.32M 5.8B 95.81M 591M 232M 2.78B 241M 237M 10.18B 541M 77.58M 66.44M 61.78M 57.6M 108M 6.99B 115M 712M 280M 3.35B 291M 285M 12.27B
Net Debt - -
More financial data * Estimated data
Logo Tianjin Chase Sun Pharmaceutical Co.,Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company's main products include Chinese traditional formula granules, Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, bulk drugs and excipient, among others. The Company also provides medical apparatus and instrument. The Company distributes its products in domestic market and to overseas markets.
Employees
5,297
More about the company
Date Price Change Volume
26-01-12 3.670 ¥ +0.55% 51,026,260
26-01-09 3.650 ¥ +0.83% 41,334,440
26-01-08 3.620 ¥ +0.84% 31,216,860
26-01-07 3.590 ¥ -0.83% 30,292,020
26-01-06 3.620 ¥ +0.56% 32,464,700

End-of-day quote Shenzhen S.E., January 08, 2026

More quotes
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.670CNY
Average target price
4.300CNY
Spread / Average Target
+17.17%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300026 Stock